Escape Therapeutics, Escape Therapeutics, Inc. is an early stage biotechnology company focused on accelerating the commercial availability of allogeneic stem cell therapies by solving the key translational hurdle preventing their clinical utility - immune mismatch and subsequent donor rejection.